Imunon, Inc.
IMNNCIK 0000749647 · last filing Jul 7, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
9,172 bought / 920 sold
net +8,252 sh · +$15.8K
- buys
- 4
- sells
- 1
- insiders active
- 4
Filing tape
Filed Tue, Jul 7, 2026
- +4,410 sh · $8.4K
Tardugno Michael H — Executive Chairman of Board · Director
- Granted4,410Common Stock@ $1.91→ 64,396 held
- +0 sh · $28
Eylward Susan — General Counsel and Corp Sec
- Granted920Common Stock@ $1.91→ 3,816 held
- Sold920Common Stock@ $1.88→ 2,896 held
- +1,308 sh · $2.5K
Faller Douglas Vincent — Chief Medical Officer
- Granted1,308Common Stock@ $1.91→ 23,204 held
- +2,534 sh · $4.8K
Lindborg Stacy — President and CEO · Director
- Granted2,534Common Stock@ $1.91→ 76,722 held
Insiders on this tape
- Tardugno Michael HExecutive Chairman of Board · Director
- Eylward SusanGeneral Counsel and Corp Sec
- Faller Douglas VincentChief Medical Officer
- Lindborg StacyPresident and CEO · Director
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.